Sirtuin-NAD Activator in Alzheimer's Disease

Clinical trial NCT05040321 · COMPLETED

Trial details

NCT number: NCT05040321
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease (Incl Subtypes)Dementia

Start date: 2021-12-01
Primary completion: 2025-12-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.